CN106265696A - 使用复合维生素b、c组合物促进胃肠系统动力的方法 - Google Patents

使用复合维生素b、c组合物促进胃肠系统动力的方法 Download PDF

Info

Publication number
CN106265696A
CN106265696A CN201510321294.2A CN201510321294A CN106265696A CN 106265696 A CN106265696 A CN 106265696A CN 201510321294 A CN201510321294 A CN 201510321294A CN 106265696 A CN106265696 A CN 106265696A
Authority
CN
China
Prior art keywords
vitamin
parts
composition
group
gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510321294.2A
Other languages
English (en)
Chinese (zh)
Inventor
周明东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zensun Shanghai Science and Technology Ltd
Original Assignee
Zensun Shanghai Science and Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zensun Shanghai Science and Technology Ltd filed Critical Zensun Shanghai Science and Technology Ltd
Priority to CN202010700288.9A priority Critical patent/CN111803514A/zh
Priority to CN201510321294.2A priority patent/CN106265696A/zh
Priority to US15/735,568 priority patent/US10881639B2/en
Priority to CA2989214A priority patent/CA2989214A1/en
Priority to AU2016276482A priority patent/AU2016276482A1/en
Priority to BR112017026834-5A priority patent/BR112017026834A2/pt
Priority to PCT/CN2016/084938 priority patent/WO2016197889A1/zh
Priority to EP16806787.4A priority patent/EP3308787A4/en
Priority to JP2017564367A priority patent/JP2018521031A/ja
Publication of CN106265696A publication Critical patent/CN106265696A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201510321294.2A 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法 Pending CN106265696A (zh)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CN202010700288.9A CN111803514A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法
CN201510321294.2A CN106265696A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法
US15/735,568 US10881639B2 (en) 2015-06-12 2016-06-06 Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility
CA2989214A CA2989214A1 (en) 2015-06-12 2016-06-06 Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility
AU2016276482A AU2016276482A1 (en) 2015-06-12 2016-06-06 Use of composition of vitamin complex in preparing drug for stimulating gastrointestinal system motility
BR112017026834-5A BR112017026834A2 (pt) 2015-06-12 2016-06-06 composição compreendendo vitaminas b e vitaminas c e seu uso
PCT/CN2016/084938 WO2016197889A1 (zh) 2015-06-12 2016-06-06 复合维生素组合物在制备促进胃肠系统动力的药物中的用途
EP16806787.4A EP3308787A4 (en) 2015-06-12 2016-06-06 USE OF A COMPOSITION OF A VITAMIN COMPLEX FOR STIMULATING THE STOMACH-DARM-MOTILITY
JP2017564367A JP2018521031A (ja) 2015-06-12 2016-06-06 胃腸系運動を刺激するための薬物の製造におけるマルチビタミン組成物の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510321294.2A CN106265696A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010700288.9A Division CN111803514A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法

Publications (1)

Publication Number Publication Date
CN106265696A true CN106265696A (zh) 2017-01-04

Family

ID=57502901

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510321294.2A Pending CN106265696A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法
CN202010700288.9A Pending CN111803514A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202010700288.9A Pending CN111803514A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法

Country Status (8)

Country Link
US (1) US10881639B2 (https=)
EP (1) EP3308787A4 (https=)
JP (1) JP2018521031A (https=)
CN (2) CN106265696A (https=)
AU (1) AU2016276482A1 (https=)
BR (1) BR112017026834A2 (https=)
CA (1) CA2989214A1 (https=)
WO (1) WO2016197889A1 (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079008A (zh) * 2016-11-23 2018-05-29 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物
CN108567792A (zh) * 2017-03-07 2018-09-25 上海泽生科技开发股份有限公司 一种治疗阿尔茨海默病的复合维生素组合物
WO2019206107A1 (zh) * 2018-04-28 2019-10-31 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物及其制备方法
CN113194749A (zh) * 2018-12-11 2021-07-30 帝斯曼知识产权资产管理有限公司 核黄素的有益于肠道健康的用途
CN115003172A (zh) * 2020-02-12 2022-09-02 帝斯曼知识产权资产管理有限公司 抗氧化剂至肠道的直接递送

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210228586A1 (en) * 2018-06-08 2021-07-29 Dsm Ip Assets B.V. Methods and compositions to support the growth or maintenance of oxygen-sensitive bacteria in the gastrointestinal tract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104337813A (zh) * 2013-07-23 2015-02-11 上海泽生科技开发有限公司 使用维生素b组合物促进胃肠系统动力的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322275T1 (de) * 1998-06-10 2006-04-15 Albert B Crum Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
US20080213395A1 (en) * 2004-10-14 2008-09-04 Adventures Plus Pty Ltd Method for the Treatment of Gastrointestinal and Other Disorders with an Admixture of Vitamins
JP2012019691A (ja) * 2010-06-17 2012-02-02 Morinaga Milk Ind Co Ltd 腎疾患患者用経口栄養組成物
CN104997803B (zh) 2010-07-22 2019-07-09 雷文制药有限公司 包含使用磁偶极子稳定化溶液的治疗或改善疾病并增强表现的方法和组合物
CN104256652A (zh) 2014-10-08 2015-01-07 李明刚 一种口服复合维生素纳米脂质体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104337813A (zh) * 2013-07-23 2015-02-11 上海泽生科技开发有限公司 使用维生素b组合物促进胃肠系统动力的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李定国等: "《常用药物用药兵法》", 30 November 2014, 武汉：湖北科学技术出版社 *
艾齐等: "《不可不知的食疗常识》", 31 July 2012, 哈尔滨：黑龙江科学技术出版社 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11351171B2 (en) 2016-11-23 2022-06-07 Zensun (Shanghai) Science & Technology, Co., Ltd. Composite vitamin composition promoting gastrointestinal system motility
WO2018095209A1 (zh) * 2016-11-23 2018-05-31 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物
US12390466B2 (en) 2016-11-23 2025-08-19 Zensun (Shanghai) Science & Technology, Co., Ltd. Composite vitamin composition promoting gastrointestinal system motility
CN110022882A (zh) * 2016-11-23 2019-07-16 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物
US11759463B2 (en) 2016-11-23 2023-09-19 Zensun (Shanghai) Science & Technology, Co., Ltd. Composite vitamin composition promoting gastrointestinal system motility
CN108079008A (zh) * 2016-11-23 2018-05-29 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物
JP2023011769A (ja) * 2017-03-07 2023-01-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． アルツハイマー病を予防し、治療し、又は遅延させるための薬物の調製におけるビタミン組成物の使用
CN110520135A (zh) * 2017-03-07 2019-11-29 上海泽生科技开发股份有限公司 维生素组合物在制备用于预防、治疗或延迟阿尔茨海默病的药物中的用途
CN108567792A (zh) * 2017-03-07 2018-09-25 上海泽生科技开发股份有限公司 一种治疗阿尔茨海默病的复合维生素组合物
WO2019206107A1 (zh) * 2018-04-28 2019-10-31 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物及其制备方法
US12144893B2 (en) 2018-04-28 2024-11-19 Zensun (Shanghai) Science & Technology, Co., Ltd. Composition of multivitamin for stimulating gastrointestinal system motility and preparation method therefor
CN113194749A (zh) * 2018-12-11 2021-07-30 帝斯曼知识产权资产管理有限公司 核黄素的有益于肠道健康的用途
CN115003172A (zh) * 2020-02-12 2022-09-02 帝斯曼知识产权资产管理有限公司 抗氧化剂至肠道的直接递送

Also Published As

Publication number Publication date
BR112017026834A2 (pt) 2018-08-14
EP3308787A4 (en) 2019-01-16
CN111803514A (zh) 2020-10-23
CA2989214A1 (en) 2016-12-15
US10881639B2 (en) 2021-01-05
EP3308787A1 (en) 2018-04-18
AU2016276482A1 (en) 2018-01-18
US20180353469A1 (en) 2018-12-13
WO2016197889A1 (zh) 2016-12-15
JP2018521031A (ja) 2018-08-02

Similar Documents

Publication Publication Date Title
US12390466B2 (en) Composite vitamin composition promoting gastrointestinal system motility
US10881639B2 (en) Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility
WO2015010449A1 (zh) 使用维生素b组合物促进胃肠系统动力的方法
ES2626651T3 (es) Composiciones para el tratamiento de la fatiga crónica
EP3395341B1 (en) Composition for treating motor neuron diseases and use thereof
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
CN110403945B (zh) 促进胃肠系统动力的复合维生素组合物及其制备方法
US12144893B2 (en) Composition of multivitamin for stimulating gastrointestinal system motility and preparation method therefor
RU2721606C1 (ru) Фармацевтическая композиция для парентерального капельного введения
JP5114394B2 (ja) 疲労回復のための医薬
CN120837471A (zh) 组合物改善高苯丙氨酸血症的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
CB02 Change of applicant information

Address after: 201203 Shanghai Curie road in Pudong New Area Zhangjiang hi tech Park No. 68

Applicant after: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, Co.,Ltd.

Address before: 201203 Shanghai Curie road in Pudong New Area Zhangjiang hi tech Park No. 68

Applicant before: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY Ltd.

CB02 Change of applicant information
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170104

RJ01 Rejection of invention patent application after publication